Advertisement
Advertisement
CLPT
ClearPoint Neuro, Inc. Common Stock
9.69
USDSponsored
+0.65
+7.19%
Oct 27, 15:59 UTC -4
Closed
Pre-Market
9.59
-0.10
-1.08%
ClearPoint Neuro, Inc. Common Stock (CLPT) Earnings
CLPT Earnings Reports
Positive Surprise Ratio
CLPT beat 15 of 29 last estimates.
52%
Next Report
Today AMC
Date of Next Report
Oct 28, 2026
Estimate for Q3 26 (Revenue/ EPS)
$12.55M
/-$0.32
Implied change from Q2 26 (Revenue/ EPS)
+15.31%
/-15.79%
Implied change from Q3 25 (Revenue/ EPS)
+41.59%
/+52.38%
ClearPoint Neuro, Inc. Common Stock earnings per share and revenue
On Aug 03, 2026, CLPT reported earnings of -0.38 USD per share (EPS) for Q2 26, missing the estimate of -0.29 USD, resulting in a -29.96% surprise. Revenue reached 10.88 million, compared to an expected 12.99 million, with a -16.23% difference. The market reacted with a -16.29% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of -0.32 USD, with revenue projected to reach 12.55 million USD, implying an decrease of -15.79% EPS, and increase of 15.31% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Integra LifeSciences Holdings
Report Date
Oct 21, 2026 For Q3 26
Estimate
$0.57
Actual
$0.59
Surprise
+3.04%
Beta Bionics, Inc. Common Stock
Report Date
Oct 27, 2026 For Q3 26
Estimate
-$0.53
Actual
-$0.52
Surprise
+2.73%
OrthoPediatrics Corp. Common Stock
Report Date
Oct 27, 2026 For Q3 26
Estimate
-$0.21
Actual
-$0.23
Surprise
-4.88%
Thermo Fisher Scientific, Inc.
Report Date
Oct 21, 2026 For Q3 26
Estimate
$6.46
Actual
$6.68
Surprise
+3.29%
Intuitive Surgical Inc.
Report Date
Oct 20, 2026 For Q3 26
Estimate
$2.69
Actual
$3.00
Surprise
+11.29%
IQVIA Holdings Inc.
Report Date
Oct 27, 2026 For Q3 26
Estimate
$3.30
Actual
$3.34
Surprise
+0.97%
FAQ
What were ClearPoint Neuro, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, ClearPoint Neuro, Inc. Common Stock reported EPS of -$0.38, missing estimates by -29.96%, and revenue of $10.88M, -16.23% below expectations.
How did the market react to ClearPoint Neuro, Inc. Common Stock's Q2 2026 earnings?
The stock price moved down -16.29%, changed from $15.38 before the earnings release to $12.88 the day after.
When is ClearPoint Neuro, Inc. Common Stock expected to report next?
The next earning report is scheduled for Oct 28, 2026.
What are the forecasts for ClearPoint Neuro, Inc. Common Stock's next earnings report?
Based on 4
analysts, ClearPoint Neuro, Inc. Common Stock is expected to report EPS of -$0.32 and revenue of $12.55M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.